Back to MW MARSHALL WACE, LLP
CADL5 quarters
Position history for MWMARSHALL WACE, LLP's holdings in CANDEL THERAPEUTICS INC
MARSHALL WACE, LLP holds 300,641 shares of CADL (CANDEL THERAPEUTICS INC), worth $3.1M as of 2026-Q2. This is a new position. CADL represents 0.0% of MARSHALL WACE, LLP's portfolio.
Current Value
$3.1M
Current Shares
300,641
Total Value Change
+$1.8M
Total Shares Change
+66,044
Quarter-by-Quarter History
Other major holders of CADL: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.